Heads are rolling?



















Q2 #'s abysmal. down $201m from Q2 2021. COVID really made our lab. No wonder we are buying and cutting! On pace to do $730M with Q2 revenue. Probably lower factoring in COVID payments for work completed in Q1. We need to dump BRL and keep the genetics labs.